4Lu cL,Chen CY,Chang FY,et al.Effect of a calium channel blocker and antispasmodic in diarrhea-predominant irritable bowel syndrome.J Castroenterol Hepatol,2000,15(8):925. 被引量：1
5Baxendale A,Bountra C,Clayton N,et al.Irritable bowel syndrome as visceral hyperal-gesia implications for therapy Current opnion in CPNS investigational.Drugs,1999,1 (1):86. 被引量：1
6Kim DY,Camil 1 eri M.Serotonin:a mediator of the brain-gut connection.Am J Gastroenterology,2000,95:2698. 被引量：1
7Read NW,Abitbol jl,Bardban KD,et al.Efficacy and safety of the penpheral kappa agonist fedozine versus placebo in the treatment of functional dyspepsia.Gut,1997,41:664. 被引量：1
8Dapongny M,Abitbol JL,Fraitag B.Efficacy of penpheral kappa agonist fedotozine versus placebo in the treatment of irritable bowel syndrome; a multicenter dose-response study.Dig Dis Sci,1995,40:2244. 被引量：1
9Jackson JL,O ' MalleyPG,TomkinsG,et al.Treatment of functional gastrointestinaldisorders with antidepressant medications ; a meta analysis.Am J Med,2000,108 (1):65. 被引量：1
10Clouse RE,Lustman PJ,Gersman RA,et al.Antidepressan therapy.in 138 patients with irritable bowel syndrome:a five year clinical expense.Aliment Phmarmcol Ther,1994,8:409. 被引量：1
